Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) Revenue (2018 - 2025)

Historic Revenue for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $143.8 million.

  • TransMedics' Revenue rose 3223.77% to $143.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $566.4 million, marking a year-over-year increase of 4120.37%. This contributed to the annual value of $441.5 million for FY2024, which is 8273.92% up from last year.
  • As of Q3 2025, TransMedics' Revenue stood at $143.8 million, which was up 3223.77% from $157.4 million recorded in Q2 2025.
  • In the past 5 years, TransMedics' Revenue registered a high of $157.4 million during Q2 2025, and its lowest value of $5.4 million during Q3 2021.
  • Over the past 5 years, TransMedics' median Revenue value was $52.5 million (recorded in 2023), while the average stood at $65.9 million.
  • Per our database at Business Quant, TransMedics' Revenue crashed by 3210.84% in 2021 and then surged by 37446.89% in 2022.
  • Quarter analysis of 5 years shows TransMedics' Revenue stood at $8.5 million in 2021, then surged by 267.17% to $31.4 million in 2022, then skyrocketed by 158.72% to $81.2 million in 2023, then skyrocketed by 49.83% to $121.6 million in 2024, then rose by 18.25% to $143.8 million in 2025.
  • Its Revenue was $143.8 million in Q3 2025, compared to $157.4 million in Q2 2025 and $143.5 million in Q1 2025.